Aclidinium
Aclidinium is a long-acting anticholinergic (muscarinic antagonist) bronchodilator. It relaxes the smooth muscle of the airways to improve airflow and reduce shortness of breath in patients with chronic obstructive pulmonary disease (COPD). It is used for daily maintenance and is not intended for the relief of acute bronchospasm.
Dosage by Body Weight
The standard adult dosage is one inhalation of 400 mcg twice daily (once in the morning and once in the evening) using the dry powder inhaler device. It is not approved for pediatric use.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients. Not indicated for this population.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients. Not indicated for this population.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients. Not indicated for this population.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients. Not indicated for this population.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients. Not indicated for this population.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric patients. Not indicated for this population. |
| 5-7 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric patients. Not indicated for this population. |
| 8-10 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric patients. Not indicated for this population. |
| 11-15 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric patients. Not indicated for this population. |
| 16-20 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric patients. Not indicated for this population. |
Formulation
Purpose
Long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Generic Name
Aclidinium bromideBranded Drug Names
Aclidinium is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.